Product

臺灣汎生製藥廠股份有限公司,網站更新中,造成不便請多包涵,歡迎指教~ ~~~

Home ANTI-TUMOR AGENTS PANBICIN Inj.

PANBICIN Inj.

DOH PM 047552


< Composition >
Each ml contains:
Epirubicin HCl..................2 mg

< Indication >
Breast cancer, adjuvant and metastatic, gastric cancer, Hodgkin’s disease, lung cancer (small and non-small cell), non-Hodgkin’s lymphoma, ovarian cancer.








< Dosage and Administration >
It is administered to patients by intravenous infusion. It is given in repeated 3 to 4 week cycles. The total dose of epirubicin may be given on day 1 of each cycle or divided equally and given on day 1 and 8 of each cycle. The recommended adult starting dose of epirubicin is 60 to 90 mg/m2 (area of body surface).

< Package >
10 ml /ampoule.


Subscribe to Latest NewsSubscribe to Latest News Subscribe to Merchandise NewsSubscribe to Merchandise News  
Powered by www.url.com.tw